1. Masago, Katsuhiro, Kuroda, Hiroaki, Sasaki, Eiichi, Hanai, Nobuhiro, Matsushita, Hirokazu. 2024. Novel gene fusions in human oropharyngeal carcinoma. In Cancer genetics, 286-287, 29-34. doi:10.1016/j.cancergen.2024.06.004. https://pubmed.ncbi.nlm.nih.gov/38971117/
2. Mogilevsky, Maxim, Shimshon, Odelia, Kumar, Saran, Heyd, Florian, Karni, Rotem. . Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment. In Nucleic acids research, 46, 11396-11404. doi:10.1093/nar/gky921. https://pubmed.ncbi.nlm.nih.gov/30329087/
3. Wang, Jing, Da, Chaoling, Su, Ye, Song, Ruijia, Bai, Zhifeng. 2021. MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b. In Biochemical and biophysical research communications, 556, 31-38. doi:10.1016/j.bbrc.2021.02.084. https://pubmed.ncbi.nlm.nih.gov/33836345/
4. Zhang, Y-M, Fan, J-K, Wang, X-Y, Wang, X-S, Yang, X-J. . Study on MKNK2 as a potential prognostic and immunological biomarker in pan-cancer. In European review for medical and pharmacological sciences, 28, 4591-4620. doi:10.26355/eurrev_202411_36955. https://pubmed.ncbi.nlm.nih.gov/39624012/
5. Tan, Binbin, Yang, Gaohui, Su, Liangyan, Liang, Chunfeng, Lai, Yongrong. 2024. MiR-125b targeted regulation of MKNK2 inhibits multiple myeloma proliferation and invasion. In American journal of translational research, 16, 3366-3375. doi:10.62347/QWGS2351. https://pubmed.ncbi.nlm.nih.gov/39114709/
6. Wang, Xiao-Chen, Zhan, Xiao-Rong, Li, Xin-Yu, Yu, Jun-Jie, Liu, Xiao-Min. 2014. Identification and validation co-differentially expressed genes with NAFLD and insulin resistance. In Endocrine, 48, 143-51. doi:10.1007/s12020-014-0247-5. https://pubmed.ncbi.nlm.nih.gov/24699882/
智鼠故事 
